Corneal collagen crosslinking may manage superficial microbial keratitis

Article

A study published in The British Journal of Ophthalmology found that corneal collagen crosslinking appears to be an effective procedure in the management of superficial microbial keratitis.

A study published in The British Journal of Ophthalmology found that corneal collagen crosslinking appears to be an effective procedure in the management of superficial microbial keratitis.

The study looked at 15 eyes of 15 patients with microbial keratitis-nine with bacterial keratitis and six with fungal keratitis. The depth of the infiltrate was determined clinically with slit lamp and measured manually using anterior segment OCT. The patients were treated with antibiotics/antifungals, and those who did not respond to at least two weeks of topical medications underwent corneal collagen crosslinking, followed by the same preoperative topical medications. Follow-up appointments were scheduled every third day to observe signs of resolution of the microbial keratitis.

According to the study, six of the nine patients with bacterial keratitis and three of the six patients with fungal keratitis resolved after the corneal collagen crosslinking procedure. However, patients with deep stromal keratitis or endothelial plaque failed to resolve. All of the patients had resolution of pain on the first day post-op. 

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Devin Sasser, OD, shares his excitement for Acuvue Oasys MAX 1-Day multifocal for astigmatism, the first and only daily disposable multifocal toric contact lens.
Shelby Brogdon, OD, details opportunities for practices to answer the patient's concerns from the chair before they hit the internet for their contact lens needs.
Christi Closson, OD, FAAO, shares her excitement for the new Acuvue Oasys MAX 1-Day multifocal for astigmatism
Karen R. Hoffman, OD, shares how customizable scleral lenses can transform vision for patients with complex corneas, achieving 20/20 outcomes and enhanced comfort.
When Langis Michaud, OD, MSc, FAAO, FSLS, FBCLA, FEAOO, began fitting scleral lenses 20 years ago, there was limited knowledge about conjunctival characteristics, scleral shape, and lens behavior.
Ioussifova details what sets Johnson & Johnson's new lens apart from the rest, which was launched at the American Optometric Association's Optometry's Meeting 2025.
Karen R. Hoffman, OD, speaks on her AOA 2025 poster, which details a case series on fitting patients with irregular cornea and astigmatism with Zenlens (Bausch + Lomb)
Peter Hersh, MD, stated that the key takeaway from a handful of presentations he gave at CCS 2025 is that successfully treating patients with keratoconus is identifying the disease early.
Rhue and Canto-Sims talk the value of contact lens patients, financial insights, and key benefits of implementing a contact lens management system.
© 2025 MJH Life Sciences

All rights reserved.